Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Bornstein

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Acta Neurologica Scandinavica|May 7, 2014
Stroke service: how can we improve and measure outcomes? Consensus summary from a global stroke forumM M Rymer, C S Anderson, M Harada, et al.
Neurology|October 26, 1999
Antiplatelet therapy: views from the expertsJ D Easton, H C Diener, N M Bornstein, et al.
European Journal of Neurology|January 12, 2013
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activitiesS Shenhar-Tsarfaty, N Waiskopf, K Ofek, et al.
Acta Diabetologica|August 7, 2001
The state of leukocyte adhesiveness/aggregation in the peripheral blood of patients with type 2 diabetes and ischemic vascular diseaseR Fusman, R Rotstein, D Zeltser, et al.
Psychoneuroendocrinology|May 27, 2017
High hair cortisol concentrations predict worse cognitive outcome after stroke: Results from the TABASCO prospective cohort studyE Ben Assayag, O Tene, A D Korczyn, et al.
European Journal of Neurology|May 20, 2020
Practice recommendations for neurovascular ultrasound investigations of acute stroke patients in the setting of the COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral HemodynamicsC Baracchini, A Pieroni, M Kneihsl, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 28, 2012
NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onsetJ A Zivin, R Sehra, A Shoshoo, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Acta Neurologica Scandinavica|May 7, 2014
Stroke service: how can we improve and measure outcomes? Consensus summary from a global stroke forumM M Rymer, C S Anderson, M Harada, et al.
Neurology|October 26, 1999
Antiplatelet therapy: views from the expertsJ D Easton, H C Diener, N M Bornstein, et al.
European Journal of Neurology|January 12, 2013
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activitiesS Shenhar-Tsarfaty, N Waiskopf, K Ofek, et al.
Acta Diabetologica|August 7, 2001
The state of leukocyte adhesiveness/aggregation in the peripheral blood of patients with type 2 diabetes and ischemic vascular diseaseR Fusman, R Rotstein, D Zeltser, et al.
Psychoneuroendocrinology|May 27, 2017
High hair cortisol concentrations predict worse cognitive outcome after stroke: Results from the TABASCO prospective cohort studyE Ben Assayag, O Tene, A D Korczyn, et al.
European Journal of Neurology|May 20, 2020
Practice recommendations for neurovascular ultrasound investigations of acute stroke patients in the setting of the COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral HemodynamicsC Baracchini, A Pieroni, M Kneihsl, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 28, 2012
NeuroThera® Efficacy and Safety Trial-3 (NEST-3): a double-blind, randomized, sham-controlled, parallel group, multicenter, pivotal study to assess the safety and efficacy of transcranial laser therapy with the NeuroThera® Laser System for the treatment of acute ischemic stroke within 24 h of stroke onsetJ A Zivin, R Sehra, A Shoshoo, et al.
Pageof 10